{"podcast":{"title":"Lung Cancer Update","slug":"lung-cancer-update-827388","podcast_index_feed_id":827388,"rss_url":"https://feeds.captivate.fm/lung-cancer-update/","website_url":"https://www.researchtopractice.com/browse-tumor-types/lung-cancer","image_url":"https://artwork.captivate.fm/230421a8-7e2e-4fb0-b40c-3b50a1cbf78f/nstTehQJgx-Rm0qFgD_28hl9.png","author":"Dr. Neil Love","episode_count":56,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.","last_synced_at":"2026-07-15T06:20:06.840223+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388"},"episode":{"title":"Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates","slug":"lung-cancer-proceedings-from-a-session-held-during-the-2025-asco-annual-meeting-on-the-current-and-future-role-of-immunotherapy-and-antibody-drug-conjugates","published_at":"2025-07-17T18:00:00+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388/lung-cancer-proceedings-from-a-session-held-during-the-2025-asco-annual-meeting-on-the-current-and-future-role-of-immunotherapy-and-antibody-drug-conjugates","show_page_url":"https://stenobird.com/podcast/lung-cancer-update-827388","url":"https://lung-cancer-update.captivate.fm/episode/5512-asco2025-lungimmunoadc","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/9eb2f6f3-3409-40aa-bee9-767bda6dac76.mp3","summary":"Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as emerging evidence on the role of antibody-drug conjugates for patients with select actionable genomic alterations.  CME information and select publications here .","meta_description":"Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the managem…","key_points":[],"chapters":[],"topics":[],"duration_seconds":5321,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/lung-cancer-proceedings-from-a-session-held-during-the-2025-asco-annual-meeting-on-the-current-and-future-role-of-immunotherapy-and-antibody-drug-conjugates/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-update-827388/lung-cancer-proceedings-from-a-session-held-during-the-2025-asco-annual-meeting-on-the-current-and-future-role-of-immunotherapy-and-antibody-drug-conjugates.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}